November 6, 2026 - News

IM8 Targets Gummies, Hydration, and Creatine

Expansion mode.
IM8 supplement on table with powder being poured into glass
IM8

IM8 is building a platform.

What’s happening: The supplement brand’s parent co. Prenetics partnered with Authentic Brands Group, licensing Care Bears to launch gummy multivitamins for kids and adults.

Takeoff. An unprecedented rise, IM8 reached $120M ARR in year one with two SKUs. Notching 359% YoY revenue growth in Q2, it’s projecting ~$220M in ’26 and double that in ’27.

Adding $1B in growth capital, it’s entering new categories, with hydration, multivitamins, and creatine up next.

Family tree. Targeting the $50B gummy supplement market, the Care Bears deal positions IM8 as the modern-day Flintstones chewables — with plans to debut better-for-you candy and kids snacks.

Rivaling Unilever-owned Grüns—which launched kids SKUs in ’24 and recently licensed Shrek—both will ride strong subscription demand while scaling across retail.

Looking ahead: IM8 CEO Danny Yeung has ambitions to become a “truly global” supplement brand. Marketing to athletes, longevity-seekers, and kids alike, it wants to be a lifelong one too.

Ryan Deer
Ryan Deer
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.